The healthcare industry will never be the same after COVID19. Healthcare professionals need to stay aware of the latest digital health activities and keep learning from leading organizations. Digital Health […]

Previously known as North American Microbiome Congress, Microbiome Connect: Human USA is all about connecting leading academics and biotech companies presenting preclinical and clinical data, to network, educate and share […]

Microbiome Connect: Skin | 3 - 4 June 2020 | Boston, USA 2019 was a pivotal year for the skin microbiome, with multinational conglomerates moving into the space, recognizing the […]

The HR Life Sciences Virtual Event is a WFH friendly forum covering a range of topics affecting HR strategy and talent management, including telework, employee communication, training or re-training – and […]

Skin microbiome products have been gaining more momentum in the last few years with more brands starting to develop products, and personal care giants either starting to develop their own […]

CPhI & P-MEC China is your gateway to successfully grow your business at the 2nd largest pharma market in the world and your ONE-STOP SHOP pharmaceutical platform connecting the entire […]

Despite the increasingly unpredictable nature of COVID-19, our commitment to provide educational resources and networking experiences to keep pharmaceutical knowledge thriving and the industry moving forward has not wavered. Therefore, […]

Onco Cell Therapy Summit (OCTS), formerly the CAR-T Congress, is the leading digital event revolutionizing patient outcomes in cancer therapies. This virtual summit, taking place June 7 – 9, spans […]

With COVID-19 creating worldwide disruption in clinical trials and companies looking for innovative approaches to keep trials going, we at Arena International are delighted to announce the launch of our Direct […]

To keep pace with the health needs of the growing number of young and old afflicted with cancer globally, clinical development in oncology is one of the fastest growing areas within the […]

Gene Therapy for Neurological Disorders Europe is dedicated to solving the translational drug development challenges encountered in the development of gene therapies for neurological disorders. Industry pioneers from the leading pharma […]

Join the experts on this free exclusive webinar on the 16th July 2020 at 2pm BST, hosted by West Pharmaceutical Services, Inc. As the industry continues to see significant growth […]

At our first Medical Device Trials virtual event our aim is to support trial sponsors and solution providers internationally to ensure trials are delivered on time, partnerships are improved and innovations […]

Join the experts at this free exclusive webinar on the 16th July 2020 at 2pm BST, hosted by West Pharmaceutical Services, Inc.We have had over 90 registrations so far, joining us from:Abbvie, Aptar, Aptar Pharma, BI Pharma GmbH […]

Safely Harnessing Novel Targets of the Innate Immune System for Enhanced Anti-Tumor Effects The inaugural Innate Immune Stimulating Therapies Summit is focused on achieving safe and effective clinical and commercial translation of […]

Digitally Join the RNAi-Based Therapeutics Community We are excited to announce that the RNAi-Based Therapeutics Summit has gone virtual! As the first multi-disciplinary discussion for large pharma, biotech and academic leaders specifically […]

Gene therapies are revolutionizing the therapeutic landscape for rare and inherited diseases. For the field to progress, however, there are several unique and complex challenges. Perhaps the most prominent of […]

Due to the current climate, we have taken the initiative to launch our very first vaccines conference! Join industry experts from across the globe, conversing in the latest innovations in […]

With the recent Hemlibra approval and the gene therapy revolution, we are seeing a much-needed race to innovate more effective, long-lasting and curative therapies for hemophilia and acquired bleeding disorders. […]

Priming the immune system against solid tumors by leveraging immune checkpoint blockade has proven to be an effective tool in multiple malignancies. Following the success of PD1/PDL1 checkpoint inhibitors a […]

Going digital in its 2nd year, the Blood-Brain Barrier (BBB) Summit is the industry’s definitive BBB conference focused on sharing the latest scientific advances, data and key lessons learned for transporting more […]

Taking place on 3 – 4 September 2020 in Berlin, ProcureCon Pharma is your only opportunity to benchmark with the leaders of pharma procurement. Join 120+ senior procurement professionals from […]

After an exceptionally successful inaugural launch last year, the 2nd Annual Glioblastoma Drug Development Summit returns this year in an exclusive virtual format. GBM Drug Development is the only devoted meeting for large pharma, […]

SMi is proud to announce the inaugural Prefilled Syringes San Francisco event taking place in September 2020. The global pre-filled syringes market was valued at $4.9 billion in 2018 and […]

Future Pharma September 14 – 15, 2020 Boston Marriott Long Wharf, Boston, MA www.pharmaforce.wbresearch.com Future Pharma is a two-day event that brings together heads of brands and franchises, marketing, sales […]

Via the latest data driven case studies from academic and industry pioneers, the 2nd RAS Targeted Drug Development Summit (running digitally this year!) will shine a spotlight on optimizing the selectivity […]

The #1 event for oligonucleotide, peptide, CRISPR and mRNA therapeutic leaders. Join us for top-notch networking, high-level industry expert speakers, innovative company presentations, interactive scientific poster presentations, and diverse attendee […]

Transforming to a digital platform for the eleventh year, the World Bispecific Summit will continue to deliver a greater scope and penetration of innovative technical content than any other meeting. […]

Priming the immune system against solid tumors by leveraging immune checkpoint blockade has proven to be an effective tool in multiple malignancies. Following the success of PD1/PDL1 checkpoint inhibitors a […]

With deals in the protein degradation market reaching nearly $2 billion and unique degradation ideas coming into play such as LYTACs and ENDTACs, eyes are focused on how much further […]